{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:30:28Z","timestamp":1757622628875,"version":"3.44.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Medical Association Clinical Research Fund","award":["2021ZYC-A113","2021ZYC-A113","2021ZYC-A113","2021ZYC-A113","2021ZYC-A113","2021ZYC-A113","2021ZYC-A113","2021ZYC-A113"],"award-info":[{"award-number":["2021ZYC-A113","2021ZYC-A113","2021ZYC-A113","2021ZYC-A113","2021ZYC-A113","2021ZYC-A113","2021ZYC-A113","2021ZYC-A113"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05077-w","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T09:21:31Z","timestamp":1754472091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unfavorable influence of amlodipine combined with metoprolol on the short-term prognosis in hypertensive heart failure patients"],"prefix":"10.1186","volume":"25","author":[{"given":"Zu-qiu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-wei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-shan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei-hu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan-yu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-ning","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"issue":"10304","key":"5077_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"Collaboration NCDRF","year":"2021","unstructured":"Collaboration NCDRF. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104\u00a0million participants. Lancet. 2021;398(10304):957\u201380.","journal-title":"Lancet"},{"key":"5077_CR2","unstructured":"Global report on hypertension: the race against a silent killer 2023 [Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240081062."},{"issue":"4","key":"5077_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.hfc.2019.06.007","volume":"15","author":"J Slivnick","year":"2019","unstructured":"Slivnick J, Lampert BC. Hypertension and Heart Failure. Heart Fail Clin. 2019;15(4):531\u201341.","journal-title":"Heart Fail Clin."},{"issue":"3","key":"5077_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1291\/hypres.28.191","volume":"28","author":"JA Diamond","year":"2005","unstructured":"Diamond JA, Phillips RA. Hypertensive heart disease. Hypertens Res. 2005;28(3):191\u2013202.","journal-title":"Hypertens Res."},{"issue":"3","key":"5077_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/ajh.2008.356","volume":"22","author":"A Ikeda","year":"2009","unstructured":"Ikeda A, Iso H, Yamagishi K, Inoue M, Tsugane S. Blood pressure and the risk of stroke, cardiovascular disease, and all-cause mortality among Japanese: the JPHC Study. Am J Hypertens. 2009;22(3):273\u201380.","journal-title":"Am J Hypertens."},{"issue":"20","key":"5077_CR6","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","volume":"275","author":"D Levy","year":"1996","unstructured":"Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275(20):1557\u201362.","journal-title":"JAMA."},{"issue":"24","key":"5077_CR7","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","volume":"106","author":"DM Lloyd-Jones","year":"2002","unstructured":"Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D\u2019Agostino RB, Kannel WB, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106(24):3068\u201372.","journal-title":"Circulation."},{"issue":"1","key":"5077_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mcna.2016.08.012","volume":"101","author":"MA Pfeffer","year":"2017","unstructured":"Pfeffer MA. Heart Failure and Hypertension: Importance of Prevention. Med Clin North Am. 2017;101(1):19\u201328.","journal-title":"Med Clin North Am."},{"issue":"18","key":"5077_CR9","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/jama.2022.19590","volume":"328","author":"RM Carey","year":"2022","unstructured":"Carey RM, Moran AE, Whelton PK. Treatment of Hypertension: A Review. JAMA. 2022;328(18):1849\u201361.","journal-title":"JAMA."},{"issue":"9","key":"5077_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/jch.14709","volume":"25","author":"JG Wang","year":"2023","unstructured":"Wang JG, Palmer BF, Vogel Anderson K, Sever P. Amlodipine in the current management of hypertension. J Clin Hypertens (Greenwich). 2023;25(9):801\u20137.","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"5077_CR11","doi-asserted-by":"crossref","unstructured":"\u00a0Chen N, Zhou M, Yang M, Guo J, Zhu C, Yang J, et al. Calcium channel blockers versus other classes of drugs for hypertension. Cochrane Database Syst Rev. 2010;4(8):CD003654.","DOI":"10.1002\/14651858.CD003654.pub4"},{"issue":"3","key":"5077_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/HJH.0000000000000848","volume":"34","author":"C Thomopoulos","year":"2016","unstructured":"Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure\u2013meta-analyses of randomized trials. J Hypertens. 2016;34(3):373\u2009\u2212\u200984; discussion 84.","journal-title":"J Hypertens"},{"issue":"12","key":"5077_CR13","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874\u20132071.","journal-title":"J Hypertens."},{"issue":"5","key":"5077_CR14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1177\/0003319708326450","volume":"60","author":"DP Papadopoulos","year":"2009","unstructured":"Papadopoulos DP, Papademetriou V. Metoprolol succinate combination in the treatment of hypertension. Angiology. 2009;60(5):608\u201313.","journal-title":"Angiology."},{"issue":"9","key":"5077_CR15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00392-017-1115-0","volume":"106","author":"H Frohlich","year":"2017","unstructured":"Frohlich H, Torres L, Tager T, Schellberg D, Corletto A, Kazmi S, et al. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clin Res Cardiol. 2017;106(9):711\u201321.","journal-title":"Clin Res Cardiol."},{"issue":"Suppl 1","key":"5077_CR16","doi-asserted-by":"publisher","first-page":"I98","DOI":"10.1007\/s003950070017","volume":"95","author":"A Hjalmarson","year":"2000","unstructured":"Hjalmarson A, Fagerberg B. MERIT-HF mortality and morbidity data. Basic Res Cardiol. 2000;95(Suppl 1):I98-103.","journal-title":"Basic Res Cardiol."},{"issue":"33","key":"5077_CR17","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J."},{"issue":"1","key":"5077_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AEW Johnson","year":"2023","unstructured":"Johnson AEW, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S, et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10(1):1.","journal-title":"Sci Data."},{"issue":"10022","key":"5077_CR19","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957\u201367.","journal-title":"Lancet."},{"issue":"9386","key":"5077_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","volume":"362","author":"S Yusuf","year":"2003","unstructured":"Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362(9386):777\u201381.","journal-title":"Lancet."},{"issue":"7","key":"5077_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s11886-022-01706-4","volume":"24","author":"D Canoy","year":"2022","unstructured":"Canoy D, Nazarzadeh M, Copland E, Bidel Z, Rao S, Li Y, et al. How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease? Curr Cardiol Rep. 2022;24(7):851\u201360.","journal-title":"Curr Cardiol Rep."},{"issue":"25","key":"5077_CR22","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"group Sw","year":"2021","unstructured":"22. group Sw, collaboration ESCCr. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439-54.","journal-title":"Eur Heart J"},{"issue":"25 Suppl 2","key":"5077_CR23","first-page":"S49","volume":"129","author":"DC Goff Jr","year":"2014","unstructured":"Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Gibbons R, et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S49-73.","journal-title":"Circulation."},{"issue":"6","key":"5077_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.5543\/tkda.2022.69570","volume":"51","author":"M Karakayali","year":"2023","unstructured":"Karakayali M, Pusuroglu H, Altunova M, Yilmaz E, Gullu A. Predictive Value of the SCORE, SCORE2, and Pooled Cohort Risk Equation Systems in Patients with Hypertension. Turk Kardiyol Dern Ars. 2023;51(6):407\u201314.","journal-title":"Turk Kardiyol Dern Ars."},{"issue":"8","key":"5077_CR25","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.jacc.2003.11.037","volume":"43","author":"JL Rouleau","year":"2004","unstructured":"Rouleau JL, Roecker EB, Tendera M, Mohacsi P, Krum H, Katus HA, et al. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. J Am Coll Cardiol. 2004;43(8):1423\u20139.","journal-title":"J Am Coll Cardiol."},{"issue":"2 Pt 1","key":"5077_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0002-8703(99)70110-9","volume":"138","author":"ML Kukin","year":"1999","unstructured":"Kukin ML, Freudenberger RS, Mannino MM, Kalman J, Steinmetz M, Buchholz-Varley C, et al. Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure. Am Heart J. 1999;138(2 Pt 1):261\u20138.","journal-title":"Am Heart J."},{"issue":"11","key":"5077_CR27","doi-asserted-by":"publisher","first-page":"784","DOI":"10.7326\/0003-4819-150-11-200906020-00006","volume":"150","author":"FA McAlister","year":"2009","unstructured":"McAlister FA, Wiebe N, Ezekowitz JA, Leung AA, Armstrong PW. Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med. 2009;150(11):784\u201394.","journal-title":"Ann Intern Med."},{"issue":"7","key":"5077_CR28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jacc.2007.04.060","volume":"50","author":"S Bangalore","year":"2007","unstructured":"Bangalore S, Messerli FH, Kostis JB, Pepine CJ. Cardiovascular protection using beta-blockers: a critical review of the evidence. J Am Coll Cardiol. 2007;50(7):563\u201372.","journal-title":"J Am Coll Cardiol."},{"issue":"9","key":"5077_CR29","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.595496","volume":"113","author":"B Williams","year":"2006","unstructured":"Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113(9):1213\u201325.","journal-title":"Circulation."}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05077-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05077-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05077-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T21:16:55Z","timestamp":1757366215000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05077-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5077"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05077-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with the Declaration of Helsinki, The Ethics Committee of No.906 Hospital of PLA Join Logistics Support Force deemed that this research is based on open-source data, so the need for ethics approval was waived. Informed consent was obtained from all participants for the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"582"}}